Parexel International Corp (PRXL)

87.11
0.10 0.11
NASDAQ : Health Care
Prev Close 87.01
Open 87.08
Day Low/High 86.97 / 87.18
52 Wk Low/High 56.00 / 76.17
Volume 60.58K
Avg Volume 1.21M
Exchange NASDAQ
Shares Outstanding 51.05M
Market Cap 4.44B
EPS 2.90
P/E Ratio 38.35
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of PAREXEL International Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PAREXEL...

PAREXEL INTERNATIONAL CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale To Pamplona Capital Management, LLP

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of PAREXEL International Corporation ("PAREXEL") (NasdaqGS: PRXL) concerning...

INVESTOR ALERT: Levi & Korsinsky, LLP Remind Investors Of An Investigation Concerning Whether The Sale Of PAREXEL International Corporation To Pamplona Capital Management, LLP Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased PAREXEL International Corporation (NASDAQ:PRXL) stock  prior to June 20, 2017 .

Stocks Lower as Crude Oil Slides on Supply Concerns

Stocks Lower as Crude Oil Slides on Supply Concerns

Stocks are lower as crude oil plummets.

Steep Selloff Pulls Crude Into Bear Market, S&P 500 and Nasdaq Trade Lower

Steep Selloff Pulls Crude Into Bear Market, S&P 500 and Nasdaq Trade Lower

Stocks are mostly lower as crude oil plummets.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of PAREXEL International Corporation To Pamplona Capital Management, LLP Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased PAREXEL International Corporation (NASDAQ:PRXL) stock  prior to June 20, 2017 .

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low

Futures mixed even as crude oil plummets.

Parexel to Be Taken Off Market by Private Equity

Parexel to Be Taken Off Market by Private Equity

Pamplona agrees to take the pharmaceutical research company off the Nasdaq for $88.10 per share in a deal valuing the company at $5 billion.

PAREXEL International Enters Definitive Agreement To Be Acquired By Pamplona Capital Management For $88.10 Per Share In Cash

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona Capital Management, LLP (Pamplona) today announced that they have entered into a definitive agreement...

PAREXEL Introduces Its Connected Journey™ Of Newly Integrated Data-Driven Services To Simplify Drug Development And Commercialization

As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, PAREXEL International Corporation (NASDAQ: PRXL), a leading global...

PAREXEL's Alberto Grignolo Named Fellow By Drug Information Association (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, Ph.

PAREXEL Collaborates With Sanofi To Advance The Use Of Wearable Devices In Life Science Industry

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced a collaboration with Sanofi to advance the use of wearable devices to transform the collection of...

PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2017

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that several of its experts will discuss key issues facing the industry at the 53rd Drug...

Starboard's Smith Launches Campaign To Ensure Parexel Finds a Buyer

Starboard's Smith Launches Campaign To Ensure Parexel Finds a Buyer

The life sciences consulting firm likely has until October to sell itself otherwise it could find itself in the midst of a director-election battle.

Parexel Stock Jumps, May Explore Sale

Parexel Stock Jumps, May Explore Sale

The stock was up nearly 8% on Monday afternoon.

Parexel Stock Rises, May Explore Sale

Parexel Stock Rises, May Explore Sale

Parexel Int'l shares were up more than 7% Monday afternoon

PAREXEL International Reports Third Quarter Fiscal Year 2017 Results

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services company, today reported financial results for the third quarter of Fiscal Year 2017, which ended on March 31, 2017.

Parexel International Announces Date Of Third Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2017 on Wednesday, May 3, 2017 after the close of the stock market.

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

The midcap drug maker is finding growth as an outsourcing destination.

PAREXEL Ranked A Top CRO In CenterWatch Global Investigative Site Relationship Survey

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it was named a top contract research organization (CRO) in the CenterWatch 2017 Global...

PAREXEL Launches Patient Sensor Solution To Transform Clinical Trial Data Collection

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new offering that securely captures, transmits, stores,...

PAREXEL Named A FlexJobs Top 100 Company To Watch For Telecommuting And Remote Jobs In 2017

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting and Remote Jobs...

PAREXEL International Appoints Simon Harford As Senior Vice President And Chief Financial Officer

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Simon Harford as Senior Vice President and Chief Financial Officer effective June 1,...

PAREXEL International To Participate At Cowen & Co. Health Care Conference And Barclays Global Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be participating at two investor conferences in March.